Corvus Pharmaceuticals, Inc.
CRVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62 | -$27 | -$41 | -$43 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $4 |
| Change in WC | -$2 | -$4 | $1 | -$3 |
| Other Non-Cash | $35 | $4 | $10 | $5 |
| Operating Cash Flow | -$25 | -$24 | -$27 | -$37 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$0 |
| Inv. Purchases | -$70 | -$47 | -$66 | -$9 |
| Inv. Sales/Matur. | $43 | $63 | $43 | $31 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$27 | $16 | -$23 | $22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $16 | $8 | $0 | $61 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $33 | $0 | $0 | $1 |
| Financing Cash Flow | $49 | $8 | $0 | $62 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4 | -$1 | -$50 | $47 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13 | $13 | $63 | $16 |
| End Cash | $9 | $13 | $13 | $63 |
| Free Cash Flow | -$25 | -$24 | -$27 | -$37 |